Kane Biotech GAAP EPS of -$0.01, revenue of $0.84M

Aug. 25, 2022 4:59 PM ETKane Biotech Inc. (KNBIF), KNE:CABy: Urvi Shah, SA News Editor
  • Kane Biotech press release (OTCQB:KNBIF): Q2 GAAP EPS of -$0.01.
  • Revenue of $0.84M (+200.0% Y/Y).
  • Cash at June 30, 2022 was $2.5 million.
  • Gross profit for the second quarter of 2022 was $639,215, an increase of 665% compared to $83,584 for the quarter ended

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.